Overall survival and radiographic progression-free survival trends demonstrate treatment benefit of abiraterone acetate in prostate cancer. Overall survival and radiographic progression-free survival ...
CHICAGO -- Use of metformin didn't prevent progression of low-risk localized prostate cancer in patients on active surveillance, according to data from the randomized MAST study. There was no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results